101 related articles for article (PubMed ID: 350391)
1. Phase II study of Baker's antifol in advanced colorectal cancer.
Padilla F; Correa J; Buroker T; Vaitkevicius VK
Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
[No Abstract] [Full Text] [Related]
2. Phase 2 study with Baker's Antifol in solid tumors.
Rodriguez V; Richman SP; Benjamin RS; Burgess MA; Murphy WK; Valdivieso M; Banner RL; Gutterman JU; Bodey GP; Freireich EJ
Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH
Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
[No Abstract] [Full Text] [Related]
4. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma.
McCreary RH; Moertel CG; Schutt AJ; O'Connell MJ; Hahn RG; Reitemeier RJ; Rubin J; Frytak S
Cancer; 1977 Jul; 40(1):9-13. PubMed ID: 141977
[TBL] [Abstract][Full Text] [Related]
6. Baker's antifol in children with late-stage acute lymphocytic leukemia.
Nitschke R; Vietti T; Ragab A; Dyment P
Cancer Treat Rep; 1978 Dec; 62(12):2109-10. PubMed ID: 376130
[No Abstract] [Full Text] [Related]
7. Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Vogl SE; Lanham R; Kaplan BH
Oncology; 1980; 37(5):314-5. PubMed ID: 7003455
[TBL] [Abstract][Full Text] [Related]
8. Phase I studies with Baker's Antifol (BAF) (NSC 139105).
Rodriguez V; Gottlieb J; Burgess MA; Livingston R; Wheeler W; Spitzer G; Bodey GP; Blumenschein GR; Freireich EJ
Cancer; 1976 Aug; 38(2):690-4. PubMed ID: 974989
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of ifosfamide and mesna in advanced colorectal cancer.
Kemeny N; Reichman B; Dougherty J; Lipperman R; Cheng E
Cancer Treat Rep; 1987 Jun; 71(6):663-4. PubMed ID: 3107815
[No Abstract] [Full Text] [Related]
10. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
Bukowski RM; LoBuglio A; McCracken J; Pugh R
Cancer Treat Rep; 1980; 64(12):1387-8. PubMed ID: 7471126
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
[No Abstract] [Full Text] [Related]
12. Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
Kemeny N; Yagoda A; Burchenal JH
Cancer Treat Rep; 1978 Mar; 62(3):463-4. PubMed ID: 77190
[No Abstract] [Full Text] [Related]
13. Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
Bruckner HW; Lokich JJ; Stablein DM
Cancer Treat Rep; 1982 Sep; 66(9):1713-7. PubMed ID: 7116348
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
O'Connell MJ; Shani A; Rubin J; Moertel CG
Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
[No Abstract] [Full Text] [Related]
15. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
16. Phase II study of metronidazole therapy for advanced colorectal carcinoma.
Frytak S; Moertel CG; Childs DS; Schutt AJ; Albers JW
Cancer Treat Rep; 1978 Mar; 62(3):483-5. PubMed ID: 348320
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
18. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
[No Abstract] [Full Text] [Related]
19. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
[No Abstract] [Full Text] [Related]
20. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
